Caisson Interventional Expands Facility in Maple Grove, Minnesota
02/07/2018
The company, which is owned by London-based LivaNova PLC, said it will invest $750,000 in the building expansion. The new jobs will be created within three years.
As an incentive, the Minnesota Department of Employment and Economic Development is supporting the project with a $359,850 grant from the Job Creation Fund. The company will receive the funding once it has met investment and hiring commitments.
“Caisson is developing a minimally invasive implantable heart valve system that has the potential to benefit millions of patients worldwide,” said DEED Commissioner Shawntera Hardy. “The company’s investment in jobs and facilities is helping to grow a medical device cluster that is one of the cornerstones of the Minnesota economy.”
LivaNova PLC last May invested $72 million to acquire a full stake in the company. Prior to the acquisition, LivaNova owned 49 percent of Caisson. Caisson, which was founded in 2012, is developing a heart valve system to replace severely diseased or damaged heart valves that don’t close tightly enough.
Project Announcements
Acoustical Sheetmetal Company Expands Virginia Beach, Virginia, Operations
06/17/2025
iCapital To Expand Salt Lake County, Utah, Operations
06/17/2025
ACS Manufacturing Expands Davis County, Utah, Operations
06/17/2025
JetZero Plans Greensboro, North Carolina, Headquarters-Production Operations
06/17/2025
Commercial Specialty Truck Holdings Expands Cynthiana, Kentucky, Operations
06/17/2025
Berner International Expands Shenango Township, Pennsylvania, Manufacturing Operations
06/16/2025
Most Read
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Navigating the new era of SCIF construction
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Get Your Mega Site ‘Project Ready’
Q2 2025